조회 수 637 추천 수 0 댓글 0
?

단축키

Prev이전 문서

Next다음 문서

크게 작게 위로 아래로 댓글로 가기 인쇄 수정 삭제
?

단축키

Prev이전 문서

Next다음 문서

크게 작게 위로 아래로 댓글로 가기 인쇄 수정 삭제
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to complete so may possibly be grounds for compensation. Our lawyers are operating difficult to have these hurt by the drug the compensation they are entitled to.

While bleeding is a widespread complication connected with anticoagulants, it has been alleged that Xarelto is more hazardous than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This signifies that, within the event of an emergency, sufferers could be at risk for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

In the event you or perhaps a loved one particular suffered a serious bleeding occasion soon after taking Xarelto, you may have legal recourse. For a lot more info, get Xareltolegalline.bitbucket.Org in touch with us nowadays to possess your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. In addition, they are in search of punitive damages, that are typically awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

등록된 글이 없습니다.

Board Pagination Prev 1 ... 3 4 5 6 7 8 9 10 11 12 Next
/ 12